Recent research reported by several news outlets indicates that a growing number of parents are declining vitamin K injections for their newborns, and that the trend coincides with an increase in serious bleeding among infants.
Coverage published on 6 November 2026 by Medical Xpress, The New York Times, ABC News and CIDRAP describes studies that link lower acceptance of the recommended newborn vitamin K dose to a rise in infant bleeding cases.
Background
Vitamin K is routinely offered to newborns shortly after birth because infants are born with low levels of the nutrient, which is needed for normal blood clotting. Health authorities have long recommended a single injection as a preventive measure against vitamin K deficiency bleeding, a condition that can cause serious complications in young infants.
Key Findings Reported
According to the reports, the studies found that infant bleeding associated with vitamin K deficiency has increased as more parents refuse the recommended injection. ABC News characterised the findings as showing that babies whose parents decline the shot face a greater risk of bleeding. CIDRAP, which covers infectious disease and public health, tied the increase in cases directly to reduced acceptance of the newborn dose.
Implications
The findings add to broader public health concerns about declining uptake of preventive measures offered to infants. Specific figures, study methodology and the reasons parents give for declining the injection are set out in the original reports and the underlying studies, which readers are encouraged to consult directly.
Sources
- Medical Xpress: Vitamin K deficiency on the rise as more parents decline recommended shots for their newborns
- The New York Times: Infant Bleeding Surged as Parents Rejected Vitamin K Shots, Studies Find
- ABC News: More parents are declining vitamin K shots for newborns, putting more babies at risk of bleeding: Study
- CIDRAP: Increased infant bleeding tied to lower acceptance of newborn vitamin K dose
